Journal Watch · Proceedings of the National Academy of Sciences (PNAS) · 2026

Proteolytic activation of c-MYC facilitated by DOT1L.

Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.

Sepulveda GP, Nawalaniec K, Nikorich I et al.Proceedings of the National Academy of Sciences (PNAS)3 min readPharma relevance 40/100

DOI: 10.1073/pnas.2525603123PMID: 42520114Study type: research study

TL;DR

Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.

Key findings

  • Surprisingly, we found a similarity between a conserved sequence in DOT1 proteins and the DDI-family protease catalytic motif.
  • We characterize a c-MYC sequence preceding the DNA-binding domain as a site of nuclear proteolytic cleavage, demonstrate its importance for transcription activation by c-MYC, and propose that c-MYC is activated by a protease, as previously reported for Nuclear factor erythroid 2-related factor (NRF) and SREBP transcription factors.
  • Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.

What they did

We demonstrate that DOT1L and MYC [Myc and Mondo-like (MML-1) in <i>Caenorhabditis elegans</i>] coregulate genes in the nematode model and mammalian cancer cells. Moreover, both c-MYC and MML-1 exhibit cleavage products facilitated by DOT1L function.

Full abstract (original)

Background: c-MYC is a key regulator of growth and metabolism. Functional and molecular cooperation between the H3K79 methyltransferase DOT1L and c-MYC has been reported in several human cancer types, but the nature of their interaction remains undefined.

What they did: We demonstrate that DOT1L and MYC [Myc and Mondo-like (MML-1) in <i>Caenorhabditis elegans</i>] coregulate genes in the nematode model and mammalian cancer cells. Moreover, both c-MYC and MML-1 exhibit cleavage products facilitated by DOT1L function.

Results & conclusions: Surprisingly, we found a similarity between a conserved sequence in DOT1 proteins and the DDI-family protease catalytic motif. We characterize a c-MYC sequence preceding the DNA-binding domain as a site of nuclear proteolytic cleavage, demonstrate its importance for transcription activation by c-MYC, and propose that c-MYC is activated by a protease, as previously reported for Nuclear factor erythroid 2-related factor (NRF) and SREBP transcription factors. Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.

Abstract © the authors / Proceedings of the National Academy of Sciences (PNAS) (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1073/pnas.2525603123 · PubMed 42520114.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking Proceedings of the National Academy of Sciences (PNAS) for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Proceedings of the National Academy of Sciences (PNAS) study find?

Our results suggest that DOT1L may activate c-MYC and other transcription factors in the nucleus by acting as a protease.

What type of study is this?

It is a research study, published in Proceedings of the National Academy of Sciences (PNAS) in 2026. We demonstrate that DOT1L and MYC [Myc and Mondo-like (MML-1) in <i>Caenorhabditis elegans</i>] coregulate genes in the nematode model and mammalian cancer cells.

Where can I read the original paper?

The original is at the publisher via DOI 10.1073/pnas.2525603123. PubMed ID: 42520114. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Sepulveda GP, Nawalaniec K, Nikorich I et al.. Proteolytic activation of c-MYC facilitated by DOT1L.. Proceedings of the National Academy of Sciences (PNAS) (2026). DOI: 10.1073/pnas.2525603123.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/proteolytic-activation-of-c-myc-facilitated-by-dot1l-603123/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides